XML 75 R62.htm IDEA: XBRL DOCUMENT v3.23.2
Note 9 - Equity Compensation - Stock Options (Details) - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Outstanding, shares (in shares)   2,300,791
Outstanding, weighted average exercise price (in dollars per share)   $ 6.05
Outstanding, weighted average remaining contractual term (Year) 5 years 4 months 24 days 5 years 8 months 12 days
Outstanding, aggregate intrinsic value $ 11,705,731 $ 2,287,764
Granted (in shares) 0  
Granted, weighted average exercise price (in dollars per share) $ 0  
Exercised (in shares) (520,566)  
Exercised, weighted average exercise price (in dollars per share) $ 7.12  
Forfeited (in shares) 0  
Forfeited, weighted average exercise price (in dollars per share) $ 0  
Expired (in shares) (73,262)  
Expired, weighted average exercise price (in dollars per share) $ 6.58  
Outstanding, shares (in shares) 1,706,963  
Outstanding, weighted average exercise price (in dollars per share) $ 5.70  
Exercisable, shares (in shares) 1,616,265  
Exercisable, weighted average exercise price (in dollars per share) $ 5.64  
Exercisable, weighted average remaining contractual term (Year) 5 years 3 months 18 days  
Exercisable, aggregate intrinsic value $ 11,189,810  
Vested and expected to vest, shares (in shares) 1,711,976  
Vested and expected to vest at, weighted average exercise price (in dollars per share) $ 5.71  
Vested and expected to vest, weighted average remaining contractual term (Year) 5 years 4 months 24 days  
Vested and expected to vest, aggregate intrinsic value $ 11,734,827